A 75-year-old woman presents with a hip fracture. Her medical history is remarkable for coronary artery disease. Two months previously she had a non-ST-segment elevation myocardial infarction and had a drug-eluting stent (DES) placed. She has a history of type 2 diabetes, hypertension, and hyperlipidemia.
Current Medications: Medication Dosage Aspirin 81 mg/d Clopidogrel 75 mg/d Atorvastatin 20 mg/d Metformin 1000 mg twice daily Enalapril 40 mg/d Hydrochlorothiazide 25 mg/d What would be the appropriate recommendation to the surgeon about this patient's antiplatelet therapy before hip fracture repair? What is the risk of surgical bleeding with antiplatelet agents? *This case is from Docplexus Editorial Team for educative purpose only. Source: An Orthopedic Journal
